Shawn Seong
Chief Executive Officer Shaperon
Shawn Y. Seong, M.D., Ph.D. is the Founder and Chief Executive Officer of Shaperon Inc., a Seoul-based clinical-stage biotechnology company developing novel inflammasome-targeting therapies for inflammatory and immune-mediated diseases. Under his leadership, Shaperon completed its IPO on the Korean KOSDAQ and expanded internationally with a U.S. subsidiary, Hudson Therapeutics Inc., to advance global clinical development and partnerships. Seong has guided the company’s progression of multiple clinical programs, including GPCR19-targeted treatments for atopic dermatitis and other conditions.
Seminars
Tuesday 9th June 2026
Learning How to Conduct Bioanalysis for Bispecific ADCs to Accurately Understand the Molecule as a Whole
12:00 pm
- Understanding how different components affect the analysis and how that differs from a traditional ADC
- Exploring the differences in bioanalysis from traditional ADCs and how that can be adapted for bispecific ADCs
- Integrating multiple analytical technologies to gain a holistic understanding of pharmacokinetics and stability of the molecule
